- | Country : -
- | organs : -
- | Specialty : -
Extract
The main objective of the trial is to demonstrate the pharmacodynamic equivalence of triptorelin pamoate (Pamorelin® LA 11.25 mg), applied either IM or SC, in terms of the area under the curve [AUC1-85d] for serum testosterone in patients with advanced prostate cancer.
Inclusion criteria
- advanced prostate cancer (locally advanced or metastatic)